• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Value of Quality-of-Life Metrics

Video

Traditionally, overall survival and progression-free survival have been the metrics used when evaluating treatment options in oncology. However, Genevieve Kumapley, PharmD, BCOP, suggests that quality-of-life metrics can also be extremely valuable and should be considered, especially when caring for patients with end-stage disease.

Quality-of-life metrics, psychosocial issues, and cultural and social factors need to be considered during end-of-life care, says Dr Kumapley. She explains that treatment options need to be individualized and decided upon based on appropriateness for the patient, especially in patients with end-stage disease.

Considering a treatment option’s toxicity is critical, she adds, because adverse events can have a significant impact on a patient’s quality of life.

Because of the complexity of treatment selection and patient management in oncology, Dr Kumapley explains, it is challenging for payers to incorporate quality-of-life measures into coverage and reimbursement decisions. Although it would be easier for payers to simplify the process by covering only a limited number of drugs, patients with cancers for which there are few treatment options, such as pancreatic, can benefit from new options that have been approved based on quality-of-life metrics, she says.


Related Videos
Dr Xin Hu
3 experts are featured in this series.
1 expert is featured in this series.
3 experts are featured in this series.
Katrina Ortblad, ScD, MPH, Fred Hutch Cancer Center
Molly Dean, MSW, Siftwell
Dr Xin Hu
rachel rohaidy
Dr Xin Hu
Elizabeth Jones, MD, FAAD.
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.